Episode 118: The mind boggles and the heart goes all a flutter – Part 2
In episode 118, James and Mike continue their discussion of atrial fibrillation by going into details about the evidence for treating patients with atrial fibrillation and how to make decisions between ASA/warfarin/dabigatran and also what it means to be in or out of the INR therapeutic range. At the end James gives Mike a well deserved, but late, Christmas present, and both their hearts skip a beat – but not enough to require anticoagulation.
1) Canadian Cardiovascular Society 2010 Atrial Fibrillation Guidelines
2) Warfarin vs ASA in afib
Ann Intern Med 2007;146:857-67
2) Time in therapeutic range
Can Fam Phys 2005; 51:384-5
Can Fam Phys 2003; 49:181-4
Family Practice 2004; 21:612–6
J Manag Care Pharm 2009:15:244-52
3) Event rates by INR range
4) Clopidogrel and ASA in atrial fibrillation
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!